Calcium channel blocking substances for prevention of atherosclerosis.
Orimo
H
H
Department of Geriatrics, Faculty of Medicine, University of Tokyo, Japan.
Han
S Z
SZ
Tabata
R E
RE
Stergiopoulos
K
K
Ouchi
Y
Y
Karaki
H
H
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D000818:Animals; D001161:Arteriosclerosis / Q000517:prevention & control*; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004036:Diet, Atherogenic; D004958:Estradiol / Q000494:pharmacology; D008274:Magnesium / Q000627:therapeutic use*; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D017208:Rats, Wistar; D013552:Swine; D013928:Thromboxane A2 / Q000031:analogs & derivatives / Q000494:pharmacology; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D011450:Prostaglandin Endoperoxides, Synthetic; D004958:Estradiol; D013928:Thromboxane A2; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D014700:Verapamil; D008274:Magnesium; D002118:Calcium